Hacettepe University,Faculty of Medicine

Ankara 6230

2 studies enrolling now · 10 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Clear Cell Renal Cell Carcinoma, Crohn's Disease, End Stage Kidney Disease, Hemophilia A, Hemophilia B, Hypertension, Pulmonary, Metastatic Breast Cancer, Metastatic Cancer, PFIC1, PFIC2

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC — Completed
• A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer — Running, not enrolling
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 — Completed
• Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007 — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• 89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study — Completed
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) — Completed